The FDA granted accelerated approval to the tyrosine kinase inhibitor sunvozertinib (Zegfrovy) for advanced non-small cell ...

Five individuals (3.3%) experienced peak aminotransferase levels greater than five times the ULN, and two (1.3%) had ...

Note that some links may require registration or subscription. Princess Kate Middleton shared new details about her recovery ...

Time-limited (or fixed-duration) therapy offers a treatment-free interval, potentially leading to improved quality of life ...

Prices are falling for the popular obesity treatments semaglutide (Wegovy) and tirzepatide (Zepbound), but steady access to the drugs remains challenging. The medications still amount to around $500 ...